首页> 外文期刊>Journal of Cardiovascular Development and Disease >Sox9- and Scleraxis-Cre Lineage Fate Mapping in Aortic and Mitral Valve Structures
【24h】

Sox9- and Scleraxis-Cre Lineage Fate Mapping in Aortic and Mitral Valve Structures

机译:主动脉和二尖瓣结构中的Sox9和Scleraxis-Cre谱系命运映射

获取原文
       

摘要

Heart valves are complex structures composed of a heterogeneous population of valve interstitial cells (VICs), an overlying endothelium and highly organized layers of extracellular matrix. Alterations in valve homeostasis are characteristic of dysfunction and disease, however the mechanisms that initiate and promote valve pathology are poorly understood. Advancements have been largely hindered by the limited availability of tools for gene targeting in heart valve structures during embryogenesis and after birth. We have previously shown that the transcription factors Sox9 and Scleraxis (Scx) are required for heart valve formation and in this study we describe the recombination patterns of Sox9- and Scx-Cre lines at differential time points in aortic and mitral valve structures. In ScxCre; ROSA26GFP mice, recombination is undetected in valve endothelial cells (VECs) and low in VICs during embryogenesis. However, recombination increases in VICs from post natal stages and by 4 weeks side-specific patterns are observed. Using the inducible Sox9CreERT2 system, we observe recombination in VECs and VICs in the embryo, and high levels are maintained through post natal and juvenile stages. These Cre-drivers provide the field with new tools for gene targeting in valve cell lineages during differential stages of embryonic and post natal maturation and maintenance.
机译:心脏瓣膜是复杂的结构,由瓣膜间质细胞(VIC)的异质群体,上覆的内皮细胞和细胞外基质的高度组织化层组成。瓣膜动态平衡的改变是功能障碍和疾病的特征,但是引发和促进瓣膜病理的机制了解甚少。由于在胚胎发生期间和出生后用于心脏瓣膜结构中的基因靶向工具的有限可用性,极大地阻碍了进展。我们以前已经表明,转录因子Sox9和巩膜(Scx)是心脏瓣膜形成所必需的,在这项研究中,我们描述了在主动脉和二尖瓣结构的不同时间点上Sox9-和Scx-Cre系的重组模式。在ScxCre中; ROSA26GFP小鼠,在胚胎发生过程中未在瓣膜内皮细胞(VEC)中检测到重组,在VIC中检测到低重组。然而,从出生后阶段开始,VICs的重组增加,并且观察到4周时出现侧特异性模式。使用诱导型Sox9CreERT2系统,我们观察到胚胎中VEC和VIC的重组,并且在出生后和幼年阶段都保持高水平。这些Cre驱动程序为该领域提供了新的工具,可在胚胎以及出生后成熟和维持的不同阶段针对瓣膜细胞谱系进行基因靶向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号